Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PARP inhibition in treatment of pancreatic cancer.
Hammel P, Zhang C, Matile J, Colle E, Hadj-Naceur I, Gagaille MP, Bouattour M, Cros J, de Mestier L, Lamuraglia M. Hammel P, et al. Expert Rev Anticancer Ther. 2020 Nov;20(11):939-945. doi: 10.1080/14737140.2020.1820330. Epub 2020 Sep 16. Expert Rev Anticancer Ther. 2020. PMID: 32936674 Review.
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.
Van Laethem JL, Verslype C, Iovanna JL, Michl P, Conroy T, Louvet C, Hammel P, Mitry E, Ducreux M, Maraculla T, Uhl W, Van Tienhoven G, Bachet JB, Maréchal R, Hendlisz A, Bali M, Demetter P, Ulrich F, Aust D, Luttges J, Peeters M, Mauer M, Roth A, Neoptolemos JP, Lutz M. Van Laethem JL, et al. Among authors: hammel p. Ann Oncol. 2012 Mar;23(3):570-576. doi: 10.1093/annonc/mdr351. Epub 2011 Aug 1. Ann Oncol. 2012. PMID: 21810728 Free article. Review.
Prognostic factors for resectable pancreatic adenocarcinoma.
Neuzillet C, Sauvanet A, Hammel P. Neuzillet C, et al. Among authors: hammel p. J Visc Surg. 2011 Sep;148(4):e232-43. doi: 10.1016/j.jviscsurg.2011.07.007. Epub 2011 Sep 15. J Visc Surg. 2011. PMID: 21924695 Free article. Review.
Gemcitabine in elderly patients with advanced pancreatic cancer.
Hentic O, Dreyer C, Rebours V, Zappa M, Lévy P, Raymond E, Ruszniewski P, Hammel P. Hentic O, et al. Among authors: hammel p. World J Gastroenterol. 2011 Aug 14;17(30):3497-502. doi: 10.3748/wjg.v17.i30.3497. World J Gastroenterol. 2011. PMID: 21941416 Free PMC article.
Stromal expression of SPARC in pancreatic adenocarcinoma.
Neuzillet C, Tijeras-Raballand A, Cros J, Faivre S, Hammel P, Raymond E. Neuzillet C, et al. Among authors: hammel p. Cancer Metastasis Rev. 2013 Dec;32(3-4):585-602. doi: 10.1007/s10555-013-9439-3. Cancer Metastasis Rev. 2013. PMID: 23690170 Review.
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Bachet JB, Maréchal R, Demetter P, Bonnetain F, Cros J, Svrcek M, Bardier-Dupas A, Hammel P, Sauvanet A, Louvet C, Paye F, Vaillant JC, André T, Closset J, Salmon I, Emile JF, Van Laethem JL. Bachet JB, et al. Among authors: hammel p. Eur J Cancer. 2013 Aug;49(12):2643-53. doi: 10.1016/j.ejca.2013.04.017. Epub 2013 May 28. Eur J Cancer. 2013. PMID: 23726265
417 results